{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T08:45:23Z","timestamp":1772268323774,"version":"3.50.1"},"reference-count":35,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Science and Technology Program of Traditional Chinese Medicine","award":["2019ZQ047"],"award-info":[{"award-number":["2019ZQ047"]}]},{"name":"Zhejiang Science and Technology Program of Traditional Chinese Medicine","award":["2013ZB148"],"award-info":[{"award-number":["2013ZB148"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"crossref","award":["320.6750.2020-04-44"],"award-info":[{"award-number":["320.6750.2020-04-44"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>This study aimed to conduct a network meta-analysis (NMA) to compare the efficacy of brain natriuretic peptide (BNP) vs nicorandil for preventing contrast-induced nephropathy (CIN). Databases of Pubmed, Cochrane, Embase, Web of Science were searched by keywords for eligible studies of randomized controlled trials investigating different agents (BNP, nicorandil, nitroglycerin, intravenous saline) for preventing CIN. The outcomes included a change in serum creatinine level at 48 h and the incidence of CIN after percutaneous coronary intervention (PCI) or coronary angiography (CAG). A total of 13 studies with 3,462 patients were included. Compared with intravenous saline alone, except for nitroglycerin (odds ratio [OR]: 1.02, 95% CI [0.36\u20132.88]), the other drugs significantly reduced the CIN incidence with OR of 0.35 (95% CI [0.24\u20130.51]) for BNP, 0.52 (0.29, 0.94) for usual-dose nicorandil, 0.28 (0.19, 0.43) for double-dose nicorandil. BNP and double-dose nicorandil significantly decreased the change of serum creatinine (SCr) levels with mean difference (MD) of \u22126.98, (\u221210.01, \u22123.95) for BNP, \u22128.78, (\u221211.63, \u22125.93) for double-dose nicorandil. No significant differences were observed in the change of SCr levels for nitroglycerin (\u22124.97, [\u221211.46, 1.52]) and usual-dose nicorandil (\u22122.32, [\u22125.52, 0.89]) compared with intravenous saline alone. For double-dose nicorandil, the CIN incidence and the change of SCr level in group of 4\u20135 days treatment course were more than group of less than or equal to 24 h treatment course (OR of 1.48, [0.63\u20133.46] and MD of 2.48, [\u22121.96, 6.91]). In conclusion, BNP and double-dose nicorandil can have effects on preventing the incidence of CIN and double-dose nicorandil performed better than BNP. In double-dose nicorandil groups, a course of less than or equal to 24 h before and after procedure performed with better efficacy than a course of 4\u20135 days.<\/jats:p>","DOI":"10.7717\/peerj.12975","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T03:51:24Z","timestamp":1645588284000},"page":"e12975","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of brain natriuretic peptide\n                    <i>vs<\/i>\n                    . nicorandil in preventing contrast-induced nephropathy: a network meta-analysis"],"prefix":"10.7717","volume":"10","author":[{"given":"Ziwei","family":"Mei","sequence":"first","affiliation":[{"name":"Pharmacy Department, Lishui Municipal Central Hospital, Lishui, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songmei","family":"Luo","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Lishui Municipal Central Hospital, Lishui, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peipei","family":"Chen","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Lishui Municipal Central Hospital, Lishui, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiankun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Nephrology Department, Lishui Municipal Central Hospital, Lishui, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Nephrology Department, Lishui Municipal Central Hospital, Lishui, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Nephrology Department, Lishui Municipal Central Hospital, Lishui, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Nephrology Department, Lishui Municipal Central Hospital, Lishui, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lie","family":"Jin","sequence":"additional","affiliation":[{"name":"Nephrology Department, Lishui Municipal Central Hospital, Lishui, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4443","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"issue":"5","key":"10.7717\/peerj.12975\/ref-1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/0003319716661445","article-title":"Strategies Preventing contrast-induced nephropathy after coronary angiography: a comprehensive meta-analysis and systematic review of 125 randomized controlled trials","volume":"68","author":"Ali-Hasan-Al-Saegh","year":"2017","journal-title":"Angiology"},{"issue":"4","key":"10.7717\/peerj.12975\/ref-2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11936-015-0375-0","article-title":"Statins in the prevention of contrast-induced nephropathy","volume":"17","author":"Chyou","year":"2015","journal-title":"Current Treatment Options in Cardiovascular Medicine"},{"issue":"3","key":"10.7717\/peerj.12975\/ref-3","doi-asserted-by":"publisher","first-page":"F319","DOI":"10.1152\/ajprenal.00130.2017","article-title":"Prevention of contrast-induced nephropathy by limb ischemic preconditioning: underlying mechanisms and clinical effects","volume":"314","author":"Dugbartey","year":"2018","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"11","key":"10.7717\/peerj.12975\/ref-4","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1007\/s00380-016-0809-y","article-title":"Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization","volume":"31","author":"Fan","year":"2016","journal-title":"Heart Vessels"},{"issue":"11","key":"10.7717\/peerj.12975\/ref-5","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1007\/s00380-016-0809-y","article-title":"Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization","volume":"31","author":"Fan","year":"2016","journal-title":"Heart Vessels"},{"issue":"6","key":"10.7717\/peerj.12975\/ref-6","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1159\/000503160","article-title":"Efficacy of oral nicorandil to prevent contrast-induced nephropathy in patients with chronic renal dysfunction undergoing an elective coronary procedure","volume":"44","author":"Fan","year":"2019","journal-title":"Kidney and Blood Pressure Research"},{"issue":"3","key":"10.7717\/peerj.12975\/ref-7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/joic.12379","article-title":"Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium","volume":"30","author":"Grossman","year":"2017","journal-title":"Journal of Interventional Cardiology"},{"issue":"3","key":"10.7717\/peerj.12975\/ref-8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/joic.12379","article-title":"Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium","volume":"30","author":"Grossman","year":"2017","journal-title":"Journal of Interventional Cardiology"},{"issue":"1","key":"10.7717\/peerj.12975\/ref-9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/jcem.76.1.8380606","article-title":"Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man","volume":"76","author":"Holmes","year":"1993","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.7717\/peerj.12975\/ref-10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.5603\/CJ.a2017.0028","article-title":"Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: a prospective randomized controlled trial","volume":"24","author":"Iranirad","year":"2017","journal-title":"Cardiology Journal"},{"issue":"4","key":"10.7717\/peerj.12975\/ref-11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3349\/ymj.2013.54.4.957","article-title":"Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (Principle study)","volume":"54","author":"Ko","year":"2013","journal-title":"Yonsei Medical Journal"},{"issue":"12","key":"10.7717\/peerj.12975\/ref-12","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.cjca.2014.08.012","article-title":"Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography","volume":"30","author":"Liu","year":"2014","journal-title":"Canadian Journal of Cardiology"},{"key":"10.7717\/peerj.12975\/ref-13","doi-asserted-by":"publisher","first-page":"5985327","DOI":"10.1155\/2016\/5985327","article-title":"Recombinant brain natriuretic peptide for the prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing nonemergent percutaneous coronary intervention or coronary angiography: a randomized controlled trial","volume":"2016","author":"Liu","year":"2016","journal-title":"BioMed Research International"},{"key":"10.7717\/peerj.12975\/ref-14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2015.01.046","article-title":"A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes","volume":"183","author":"Marenzi","year":"2015","journal-title":"International Journal of Cardiology"},{"issue":"13","key":"10.7717\/peerj.12975\/ref-15","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jacc.2016.05.099","article-title":"Contrast-induced acute kidney injury","volume":"68","author":"McCullough","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.7717\/peerj.12975\/ref-16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijcard.2015.05.078","article-title":"Continuous intravenous infusion of nicorandil for 4 h before and 24 h after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function","volume":"195","author":"Nawa","year":"2015","journal-title":"International Journal of Cardiology"},{"issue":"7","key":"10.7717\/peerj.12975\/ref-17","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1007\/s00330-020-06719-7","article-title":"Impact on clinical practice of updated guidelines on iodinated contrast material: CINART","volume":"30","author":"Nijssen","year":"2020","journal-title":"European Radiology"},{"issue":"9","key":"10.7717\/peerj.12975\/ref-18","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/RLI.0000000000000570","article-title":"Prophylaxis in high-risk patients with egfr <30 ml\/min\/1.73 m2: get the balance right","volume":"54","author":"Nijssen","year":"2019","journal-title":"Investigative Radiology"},{"issue":"2","key":"10.7717\/peerj.12975\/ref-19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.carj.2012.11.002","article-title":"Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012","volume":"65","author":"Owen","year":"2014","journal-title":"Canadian Association of Radiologists Journal"},{"key":"10.7717\/peerj.12975\/ref-20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-3-540-68964-5_15","article-title":"Natriuretic peptides: their structures, receptors, physiologic functions, and therapeutic applications","volume":"191","author":"Potter","year":"2009","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"9","key":"10.7717\/peerj.12975\/ref-21","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.carrev.2020.01.010","article-title":"Nicorandil reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography\/intervention - systematic review and meta-analysis of randomized controlled trials including grade qualification","volume":"21","author":"Pranata","year":"2020","journal-title":"Cardiovascular Revascularization Medicine"},{"issue":"8","key":"10.7717\/peerj.12975\/ref-22","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/heartjnl-2014-306962","article-title":"Contrast-induced nephropathy following angiography and cardiac interventions","volume":"102","author":"Rear","year":"2016","journal-title":"Heart"},{"issue":"2","key":"10.7717\/peerj.12975\/ref-23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1476-5381.2011.01231.x","article-title":"Nicorandil ameliorates ischemia-reperfusion injury in the rat kidney","volume":"163","author":"Shimizu","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.7717\/peerj.12975\/ref-24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.7326\/M15-1456","article-title":"Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis","volume":"164","author":"Subramaniam","year":"2016","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"10.7717\/peerj.12975\/ref-25","first-page":"14166","article-title":"Comparison of the efficacy of recombinant human brain natriuretic peptide with saline hydration in preventing contrast-induced nephropathy in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention","volume":"8","author":"Sun","year":"2015","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"14","key":"10.7717\/peerj.12975\/ref-26","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.105.595090","article-title":"Contrast-induced nephropathy: a clinical and evidence-based approach","volume":"113","author":"Tepel","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.7717\/peerj.12975\/ref-27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/0003319716676173","article-title":"Contrast-induced acute kidney injury is associated with long-term adverse events in patients with acute coronary syndrome","volume":"68","author":"Uzunhasan","year":"2017","journal-title":"Angiology"},{"issue":"11","key":"10.7717\/peerj.12975\/ref-28","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00228-016-2135-9","article-title":"Brain natriuretic peptide for prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials","volume":"72","author":"Wei","year":"2016","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"11","key":"10.7717\/peerj.12975\/ref-29","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00228-016-2135-9","article-title":"Brain natriuretic peptide for prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials","volume":"72","author":"Wei","year":"2016","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"4","key":"10.7717\/peerj.12975\/ref-30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00380-015-0642-8","article-title":"Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI","volume":"31","author":"Xing","year":"2016","journal-title":"Heart Vessels"},{"issue":"11","key":"10.7717\/peerj.12975\/ref-31","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s11255-019-02244-9","article-title":"Comparison of double-dose vs. usual dose of nicorandil for the prevention of contrast-induced nephropathy after cardiac catheterization","volume":"51","author":"Zeng","year":"2019","journal-title":"International Urology and Nephrology"},{"key":"10.7717\/peerj.12975\/ref-32","doi-asserted-by":"publisher","first-page":"118379","DOI":"10.1016\/j.lfs.2020.118379","article-title":"Advances in the pathogenesis and prevention of contrast-induced nephropathy","volume":"259","author":"Zhang","year":"2020","journal-title":"Life Sciences"},{"issue":"6","key":"10.7717\/peerj.12975\/ref-33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3109\/02841851.2010.486804","article-title":"B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention","volume":"51","author":"Zhang","year":"2010","journal-title":"Acta Radiologica"},{"issue":"2","key":"10.7717\/peerj.12975\/ref-34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/0003319719841733","article-title":"Preventive effects of nicorandil against contrast-induced nephropathy in patients with moderate renal insufficiency undergoing percutaneous coronary intervention","volume":"71","author":"Zhang","year":"2020","journal-title":"Angiology"},{"issue":"3","key":"10.7717\/peerj.12975\/ref-35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MCA.0000000000000826","article-title":"Efficacy of nicorandil on the prevention of contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention","volume":"31","author":"Zhang","year":"2020","journal-title":"Coronary Artery Disease"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/12975.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/12975.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/12975.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/12975.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T03:51:39Z","timestamp":1645588299000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/12975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":35,"alternative-id":["10.7717\/peerj.12975"],"URL":"https:\/\/doi.org\/10.7717\/peerj.12975","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.7287\/peerj.12975v0.1\/reviews\/2","asserted-by":"object"},{"id-type":"doi","id":"10.7287\/peerj.12975v0.1\/reviews\/1","asserted-by":"object"}]},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"article-number":"e12975"}}